Cut Timelines & Enhance Efficiency & Scalability to Deliver High-Quality DNA for Life Changing Therapies and Vaccines
Cutting-edge advances in DNA production, from high-yield plasmids to next‑gen cell‑free systems, are reshaping how biopharma delivers vaccines and nucleic acid therapeutics.
The 3rd DNA Process Development & Manufacturing Summit
brings you the practical insights needed to streamline fermentation, sharpen purification, strengthen CMC, and scale high‑quality DNA with confidence.
Unite with industry leaders such as Sanofi, Pfizer, GSK, GreenLight Biosciences, HDT Bio, and others, as well as innovative emerging players advancing new DNA formats and manufacturing technologies.
This is your premier meeting dedicated to exploring the full DNA manufacturing lifecycle, from upstream to downstream, process development to scale-up, and quality to regulatory alignment, and walk away with actionable strategies to accelerate tomorrow’s therapies.
Attending Companies Include